IH
TBI

IES Holdings’s Trueblue TBI Stock Holding History

IES Holdings’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.96M Buy
+1,285,839
New +$7.16M 2.89% 15

Other funds holding TBI

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IES Holdings's TBI Position: Q2 2026 in Review

IES Holdings opened a new position in Trueblue (TBI) in Q2 2026: 1,285,839 shares worth $8.96M. The stake represents 2.89% of the portfolio and ranks #15 among its holdings.

113 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • IES Holdings held 1,285,839 shares of Trueblue worth $8.96M as of Q2 2026.
  • Trueblue was a new IES Holdings position in Q2 2026.
  • Trueblue made up 2.89% of IES Holdings's portfolio in Q2 2026, its #15 holding.
  • 113 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on IES Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.